Brain+ A/S (CPH: BRAINP)

Market Cap	14.06M
Revenue (ttm)	6.08M
Net Income (ttm)	-462.19K
Shares Out	171.50M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	489,267
Open	0.0750
Previous Close	0.0750
Day's Range	0.0750 - 0.0856
52-Week Range	0.0600 - 0.2890
Beta	-0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Brain+

Brain+ A/S develops digital therapeutics for Alzheimer’s and dementia. It develops cognitive stimulation therapy (CST)-Assistant, a health tech solution to support scalable and delivery of group CST via a readily accessible preparation system, content adaptability and a standardized delivery form, which lessens the dependence of CST performance on therapists; CST - Home Care for use to extend and scale the delivery of CST to a home setting, enabling broader access to the therapy for a dementia population at limited costs; CST/ computerized cogn...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 20
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: BRAINP

Financial Performance

In 2018, Brain+'s revenue was 6.08 million, an increase of 40.10% compared to the previous year's 4.34 million. Losses were -462,187, -20.69% less than in 2017.